Coronavirus company news summary - SpeeDx introduces new research agents for SARS-CoV-2 variants - CityHealth to offer RapidReturn test for travellers - Verdict Medical Devices
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Coronavirus company news summary – SpeeDx introduces new research agents for SARS-CoV-2 variants – CityHealth to offer RapidReturn test for travellers

27 Jul 2021

SpeeDx has introduced a new line of research reagents for reflex variant analysis of circulating Covid-19 variants of concern. The PlexPrime SARS-CoV-2 Genotyping research reagents are intended to facilitate the identification and tracking of emerging and circulating variants by detecting specific viral mutations. These tests can be used with traditional quantitative polymerase chain reaction instrumentation.

CityHealth has launched the RapidReturn Kit for Covid-19 testing of US-bound travellers, who can obtain the rapid antigen test results within minutes from any place globally. The cost-effective pre-travel test comes with specialist support to guide travellers on the collection of samples, testing and delivery of results. Each kit consists of two tests, including sterile swabs, test strips and testing solution.

Avricore Health subsidiary HealthTab has added Abbott’s ID NOW molecular testing device to its supplier distribution agreement, which was initially signed in May this year. The device will now be used at HealthTab’s community pharmacy locations for on-site testing and reporting of the SARS-CoV-2 virus. ID NOW is also capable of detecting respiratory syncytial virus, influenza A and B, and Strep.